QQQ   387.42 (+0.03%)
AAPL   192.88 (-0.28%)
MSFT   369.50 (-0.81%)
META   320.53 (+0.70%)
GOOGL   130.90 (-0.07%)
AMZN   145.79 (-0.74%)
TSLA   244.29 (+2.33%)
NVDA   463.69 (-0.42%)
NIO   8.07 (+8.61%)
BABA   72.28 (-0.14%)
AMD   119.31 (+0.79%)
T   16.99 (-1.34%)
F   10.78 (+1.70%)
MU   73.80 (+0.15%)
CGC   0.69 (+4.28%)
GE   120.56 (+0.27%)
DIS   92.11 (+1.45%)
AMC   6.98 (-0.57%)
PFE   29.19 (+0.34%)
PYPL   60.39 (+4.26%)
XOM   99.06 (-1.37%)
QQQ   387.42 (+0.03%)
AAPL   192.88 (-0.28%)
MSFT   369.50 (-0.81%)
META   320.53 (+0.70%)
GOOGL   130.90 (-0.07%)
AMZN   145.79 (-0.74%)
TSLA   244.29 (+2.33%)
NVDA   463.69 (-0.42%)
NIO   8.07 (+8.61%)
BABA   72.28 (-0.14%)
AMD   119.31 (+0.79%)
T   16.99 (-1.34%)
F   10.78 (+1.70%)
MU   73.80 (+0.15%)
CGC   0.69 (+4.28%)
GE   120.56 (+0.27%)
DIS   92.11 (+1.45%)
AMC   6.98 (-0.57%)
PFE   29.19 (+0.34%)
PYPL   60.39 (+4.26%)
XOM   99.06 (-1.37%)
QQQ   387.42 (+0.03%)
AAPL   192.88 (-0.28%)
MSFT   369.50 (-0.81%)
META   320.53 (+0.70%)
GOOGL   130.90 (-0.07%)
AMZN   145.79 (-0.74%)
TSLA   244.29 (+2.33%)
NVDA   463.69 (-0.42%)
NIO   8.07 (+8.61%)
BABA   72.28 (-0.14%)
AMD   119.31 (+0.79%)
T   16.99 (-1.34%)
F   10.78 (+1.70%)
MU   73.80 (+0.15%)
CGC   0.69 (+4.28%)
GE   120.56 (+0.27%)
DIS   92.11 (+1.45%)
AMC   6.98 (-0.57%)
PFE   29.19 (+0.34%)
PYPL   60.39 (+4.26%)
XOM   99.06 (-1.37%)
QQQ   387.42 (+0.03%)
AAPL   192.88 (-0.28%)
MSFT   369.50 (-0.81%)
META   320.53 (+0.70%)
GOOGL   130.90 (-0.07%)
AMZN   145.79 (-0.74%)
TSLA   244.29 (+2.33%)
NVDA   463.69 (-0.42%)
NIO   8.07 (+8.61%)
BABA   72.28 (-0.14%)
AMD   119.31 (+0.79%)
T   16.99 (-1.34%)
F   10.78 (+1.70%)
MU   73.80 (+0.15%)
CGC   0.69 (+4.28%)
GE   120.56 (+0.27%)
DIS   92.11 (+1.45%)
AMC   6.98 (-0.57%)
PFE   29.19 (+0.34%)
PYPL   60.39 (+4.26%)
XOM   99.06 (-1.37%)

United Therapeutics (UTHR) Earnings Date, Estimates & Call Transcripts

$241.31
+1.00 (+0.42%)
(As of 12:02 PM ET)
Compare
Today's Range
$239.00
▼
$242.45
50-Day Range
$219.23
▼
$240.73
52-Week Range
$204.44
▼
$283.09
Volume
30,382 shs
Average Volume
390,257 shs
Market Capitalization
$11.34 billion
P/E Ratio
13.30
Dividend Yield
N/A
Price Target
$296.29
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Earnings Summary

Upcoming
Earnings Date
Feb. 28Estimated
Actual EPS
(Nov. 1)
$5.38 Beat By $0.28
Consensus EPS
(Nov. 1)
$5.10
Read Call Transcript
Listen to Call
Latest SEC 10-Q Filing
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

UTHR Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

UTHR Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

United Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20234$2.64$4.50$3.85
Q2 20234$4.49$4.59$4.53
Q3 20235$4.46$5.12$4.74
Q4 20234$3.62$4.72$4.29
FY 202317$15.21$18.93$17.41
Q1 20241$4.57$4.57$4.57
Q2 20241$5.15$5.15$5.15
Q3 20241$5.27$5.27$5.27
Q4 20241$4.59$4.59$4.59
FY 20244$19.58$19.58$19.58
Q1 20251$5.04$5.04$5.04
Q2 20251$5.37$5.37$5.37
Q3 20251$5.63$5.63$5.63

UTHR Earnings Date and Information

United Therapeutics last issued its earnings results on November 1st, 2023. The biotechnology company reported $5.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.10 by $0.28. The firm earned $609.40 million during the quarter, compared to analysts' expectations of $585.82 million. Its quarterly revenue was up 18.1% compared to the same quarter last year. United Therapeutics has generated $18.15 earnings per share over the last year ($18.15 diluted earnings per share) and currently has a price-to-earnings ratio of 13.3. Earnings for United Therapeutics are expected to grow by 13.07% in the coming year, from $19.44 to $21.98 per share. United Therapeutics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off prior year's report dates.

United Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
2/28/2024
Estimated)		------- 
11/1/2023Q3 2023$5.10$5.38+$0.28$5.38$585.82 million$609.40 million      
8/2/2023Q2 2023$4.57$5.24+$0.67$5.24$524.18 million$596.50 million      
5/3/2023Q1 2023$4.26$4.86+$0.60$4.86$514.37 million$506.90 million    
2/22/2023Q4 2022$4.12$2.67($1.45)$2.67$519.20 million$491.50 million      
11/2/2022Q3 2022$3.57$4.91+$1.34$4.91$492.92 million$516.00 million
8/3/2022Q2 2022$4.10$2.41($1.69)$2.41$461.06 million$466.90 million      
5/4/2022Q1 2022$2.96$5.03+$2.07$5.03$420.02 million$461.90 million      
2/24/2022Q4 2021$3.77$2.35($1.42)$2.35$427.59 million$415.20 million    
11/3/2021Q3 2021$3.37$3.42+$0.05$3.42$421.45 million$444.70 million    
8/4/2021Q2 2021$3.02$3.65+$0.63$3.65$378.54 million$446.50 million      
5/5/2021Q1 2021$2.60$0.61($1.99)$0.61$368.31 million$379.10 million    
2/23/2021Q4 2020$2.96$2.19($0.77)$2.19$362.04 million$384.90 million    












United Therapeutics Earnings - Frequently Asked Questions

When is United Therapeutics's earnings date?

United Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 28th, 2024 based off last year's report dates. Learn more on UTHR's earnings history.

Did United Therapeutics beat their earnings estimates last quarter?

In the previous quarter, United Therapeutics (NASDAQ:UTHR) reported $5.38 earnings per share (EPS) to beat the analysts' consensus estimate of $5.10 by $0.28. Learn more on analysts' earnings estimate vs. UTHR's actual earnings.

How can I listen to United Therapeutics's earnings conference call?

The conference call for United Therapeutics's latest earnings report can be listened to online. Listen to Conference Call

How can I read United Therapeutics's conference call transcript?

The conference call transcript for United Therapeutics's latest earnings report can be read online. Read Transcript

How can I view United Therapeutics's earnings report?

United Therapeutics's earnings report can be found in their filing with the SEC. View SEC filing

How much revenue does United Therapeutics generate each year?

United Therapeutics (NASDAQ:UTHR) has a recorded annual revenue of $1.94 billion.

How much profit does United Therapeutics generate each year?

United Therapeutics (NASDAQ:UTHR) has a recorded net income of $727.30 million. UTHR has generated $18.15 earnings per share over the last four quarters.

What is United Therapeutics's price-to-earnings ratio?

United Therapeutics (NASDAQ:UTHR) has a trailing price-to-earnings ratio of 13.30 and a forward price-to-earnings ratio of 12.41.

What is United Therapeutics's EPS forecast for next year?

United Therapeutics's earnings are expected to grow from $19.44 per share to $21.98 per share in the next year, which is a 13.07% increase.


More Earnings Resources from MarketBeat

Related Companies:
Earnings Tools:
Earnings By Country:
Latest Articles:
This page (NASDAQ:UTHR) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -